Literature DB >> 9230729

Site of pulmonary vasodilation by inhaled nitric oxide in microembolic lung injury.

C Mélot1, F Vermeulen, M Maggiorini, E Gilbert, R Naeije.   

Abstract

We investigated the site of pulmonary vasodilation and associated effects on gas exchange in response to inhaled NO in acute microembolic lung injury. Pulmonary arterial (Ppa) and effective capillary (Pc') pressures versus cardiac output (Q) plots were generated in anesthetized dogs before and after, successively, (1) embolization with 100 microns glass beads, (2) administration of either a placebo (n = 5) or 80 ppm inhaled NO followed by cyclooxygenase inhibition by aspirin 1 g given intravenously and again 80 ppm inhaled NO (n = 8). Pc' was estimated from the pressure decay curve after pulmonary artery balloon occlusion. Embolism increased pulmonary vascular resistance, with a slight decrease in its precapillary component, from 77 to 66%. NO decreased Ppa at the highest levels of Q, and aspirin increased Ppa at all levels of Q. Neither NO nor aspirin affected Pc'/Q plots or pulmonary shunt. We conclude that pulmonary vascular resistance in microembolic lung injury increases at the periphery of the pulmonary arterial tree, with partial reversibility by inhaled NO and by endogenous products of the cyclooxygenase pathway upstream from the site of effective capillary resistance. Reduced pulmonary vascular tone does not improve gas exchange in this model of acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230729     DOI: 10.1164/ajrccm.156.1.9603041

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  5 in total

1.  Increased expired NO and roles of CO2 and endogenous NO after venous gas embolism in rabbits.

Authors:  Per Agvald; L Christofer Adding; Kristofer F Nilsson; Lars E Gustafsson; Dag Linnarsson
Journal:  Eur J Appl Physiol       Date:  2006-04-21       Impact factor: 3.078

2.  Inhaled nitric oxide in patients with pulmonary embolism.

Authors:  J E Tulleken; T S van der Werf; J G Zijlstra; G Capellier; T Jacques; P Balvay; F Barale
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

3.  Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology.

Authors:  Natalia M Grob; Raed A Dweik
Journal:  J Breath Res       Date:  2008-09       Impact factor: 3.262

4.  Effect of increasing doses of magnesium in experimental pulmonary hypertension after acute pulmonary embolism.

Authors:  Nikolaus A Haas; Jan Kemke; Ingram Schulze-Neick; Peter E Lange
Journal:  Intensive Care Med       Date:  2004-09-09       Impact factor: 17.440

5.  A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension.

Authors:  Anna Stene Hurtsén; Ilya Zorikhin Nilsson; Emanuel M Dogan; Kristofer F Nilsson
Journal:  Drug Des Devel Ther       Date:  2020-02-17       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.